Kaposi's sarcoma differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 13: | Line 13: | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquired | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ||
! colspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations | ! colspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations | ||
! colspan="6" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab findings | ! colspan="6" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab findings | ||
! colspan="1" rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard diagnosis | ! colspan="1" rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard diagnosis | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | ||
|- | |- | ||
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms | ! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms | ||
Line 40: | Line 40: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Bacillary angiomatosis]] <ref name="pmid7553576">{{cite journal |vauthors=Tappero JW, Perkins BA, Wenger JD, Berger TG |title=Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus |journal=Clin. Microbiol. Rev. |volume=8 |issue=3 |pages=440–50 |date=July 1995 |pmid=7553576 |pmc=174635 |doi= |url=}}</ref> | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Bacillary angiomatosis]] <ref name="pmid7553576">{{cite journal |vauthors=Tappero JW, Perkins BA, Wenger JD, Berger TG |title=Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus |journal=Clin. Microbiol. Rev. |volume=8 |issue=3 |pages=440–50 |date=July 1995 |pmid=7553576 |pmc=174635 |doi= |url=}}</ref> | ||
| style="background:#F5F5F5;" align="left" | | | style="background:#F5F5F5;" align="left" | | ||
* HIV | * [[Human Immunodeficiency Virus (HIV)|HIV]] | ||
* Chronic lymphocytic leukemia | * [[Chronic lymphocytic leukemia]] | ||
* Cytotoxic chemotherapy | * Cytotoxic [[chemotherapy]] | ||
* Organ transplantation | * [[Organ transplant|Organ transplantation]] | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | + | | style="background:#F5F5F5;" align="center" | + | ||
| style="background:#F5F5F5;" align="center" | Any age, usually | | style="background:#F5F5F5;" align="center" | Any age, usually between 20 -50 years | ||
| style="background:#F5F5F5;" align="center" | Solitary or multiple red, purple, flesh-colored, or colorless papules | | style="background:#F5F5F5;" align="center" | Solitary or multiple red, purple, flesh-colored, or colorless [[Papule|papules]] | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | ± | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | ± | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | | ||
* Anorexia | * [[Anorexia]] | ||
* Weight loss | * [[Weight loss]] | ||
* Abdominal pain | * [[Abdominal pain]] | ||
* Nausea | * [[Nausea and vomiting]] | ||
* Headache | * [[Headache]] | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
Line 64: | Line 64: | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | Lobular vascular proliferations of vessels lined by plump endothelial cells | | style="background:#F5F5F5;" align="center" | | ||
* Lobular vascular proliferations of [[Blood vessel|vessels]] lined by plump [[Endothelium|endothelial cells]] | |||
| style="background:#F5F5F5;" align="center" | Clinical manifestation | | style="background:#F5F5F5;" align="center" | Clinical manifestation | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | | ||
*Psychiatric disorders | *[[Mental disorder|Psychiatric disorders]] | ||
*Personality changes | *[[Personality|Personality changes]] | ||
*Seizure | *[[Seizure]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Arteriovenous malformation]] <ref name="pmid23125071">{{cite journal |vauthors=Whitehead KJ, Smith MC, Li DY |title=Arteriovenous malformations and other vascular malformation syndromes |journal=Cold Spring Harb Perspect Med |volume=3 |issue=2 |pages=a006635 |date=February 2013 |pmid=23125071 |pmc=3552339 |doi=10.1101/cshperspect.a006635 |url=}}</ref> | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Arteriovenous malformation]] <ref name="pmid23125071">{{cite journal |vauthors=Whitehead KJ, Smith MC, Li DY |title=Arteriovenous malformations and other vascular malformation syndromes |journal=Cold Spring Harb Perspect Med |volume=3 |issue=2 |pages=a006635 |date=February 2013 |pmid=23125071 |pmc=3552339 |doi=10.1101/cshperspect.a006635 |url=}}</ref> | ||
| style="background:#F5F5F5;" align="left" |Idiopathic | | style="background:#F5F5F5;" align="left" | | ||
* [[Idiopathic]] | |||
* | * | ||
| style="background:#F5F5F5;" align="center" | + | | style="background:#F5F5F5;" align="center" | + | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | Any age | | style="background:#F5F5F5;" align="center" | Any age | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | + | | style="background:#F5F5F5;" align="center" | + | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | | ||
* Headache | * [[Headache]] | ||
* Neurologic deficits | * [[Neurologic diseases|Neurologic deficits]] | ||
* Heart failure | * [[Congestive heart failure|Heart failure]] | ||
* Macrocephaly | * [[Macrocephaly]] | ||
| style="background:#F5F5F5;" align="center" |Nl | | style="background:#F5F5F5;" align="center" |Nl | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
Line 93: | Line 96: | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" |NA | ||
| style="background:#F5F5F5;" align="center" | Imaging | | style="background:#F5F5F5;" align="center" | [[Imaging]] | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | | ||
* Hereditary hemorrhagic telangiectasia | * [[Hereditary hemorrhagic telangiectasia]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Acroangiodermatitis <ref name="pmid17868541">{{cite journal |vauthors=Lugović L, Pusić J, Situm M, Buljan M, Bulat V, Sebetić K, Soldo-Belić A |title=Acroangiodermatitis (pseudo-Kaposi sarcoma): three case reports |journal=Acta Dermatovenerol Croat |volume=15 |issue=3 |pages=152–7 |date=2007 |pmid=17868541 |doi= |url=}}</ref> | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Acroangiodermatitis]]<ref name="pmid17868541">{{cite journal |vauthors=Lugović L, Pusić J, Situm M, Buljan M, Bulat V, Sebetić K, Soldo-Belić A |title=Acroangiodermatitis (pseudo-Kaposi sarcoma): three case reports |journal=Acta Dermatovenerol Croat |volume=15 |issue=3 |pages=152–7 |date=2007 |pmid=17868541 |doi= |url=}}</ref> | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | | ||
| style="background:#F5F5F5;" align="center" | | * [[Idiopathic]] | ||
| style="background:#F5F5F5;" align="center" | | * Hyperplasia of pre-existing vasculature | ||
| style="background:#F5F5F5;" align="center" | | * [[Hypertension|HTN]] | ||
| style="background:#F5F5F5;" align="center" | Purplish-blue to brown papules and plaques | |||
| style="background:#F5F5F5;" align="center" | | * | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | Any age, more in males | |||
| style="background:#F5F5F5;" align="center" | Purplish-blue to brown [[Papule|papules]] and [[Plaque|plaques]] | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | | ||
* Paralysed legs | |||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
Line 115: | Line 124: | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" |Hyperkeratosis | | style="background:#F5F5F5;" align="center" | | ||
* [[Hyperkeratosis]] | |||
* Parakeratosis | |||
* [[Acanthosis nigricans|Acanthosis]] | |||
* Mild spongiosis | |||
| style="background:#F5F5F5;" align="center" | Clinical manifesttations | | style="background:#F5F5F5;" align="center" | Clinical manifesttations | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | | ||
* | * [[Amputation]] | ||
* Haemodialysis | * [[Hemodialysis|Haemodialysis]] patients with [[Arteriovenous fistula|arteriovenous shunts]] | ||
* | * [[Hepatitis C]] | ||
* [[Venous insufficiency|Chronic venous insufficiency]] | |||
* Chronic venous insufficiency | * [[Arteriovenous malformation|AV malformations]] | ||
* AV malformations | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Angiosarcoma]] <ref name="pmid2734404">{{cite journal |vauthors=Barttelbort SW, Stahl R, Ariyan S |title=Cutaneous angiosarcoma of the face and scalp |journal=Plast. Reconstr. Surg. |volume=84 |issue=1 |pages=55–9 |date=July 1989 |pmid=2734404 |doi= |url=}}</ref> | | style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Angiosarcoma]] <ref name="pmid2734404">{{cite journal |vauthors=Barttelbort SW, Stahl R, Ariyan S |title=Cutaneous angiosarcoma of the face and scalp |journal=Plast. Reconstr. Surg. |volume=84 |issue=1 |pages=55–9 |date=July 1989 |pmid=2734404 |doi= |url=}}</ref> | ||
| style="background:#F5F5F5;" align="center" | Idiopathic | | style="background:#F5F5F5;" align="center" | | ||
| style="background:#F5F5F5;" align="center" | | * [[Idiopathic]] | ||
| style="background:#F5F5F5;" align="center" | | |||
| style="background:#F5F5F5;" align="center" | | * | ||
| style="background:#F5F5F5;" align="center" |Enlarging bruise, a blue-black nodule, or an unhealed ulceration | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | Adults, more in males | ||
| style="background:#F5F5F5;" align="center" |Enlarging [[bruise]], a blue-black [[Nodule (medicine)|nodule]], or an unhealed [[Ulcer|ulceration]] | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | ↓ | | style="background:#F5F5F5;" align="center" | ↓ | ||
Line 143: | Line 158: | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | | ||
* Intercellular and intracellular lumina with or without red cells | * Intercellular and intracellular lumina with or without [[Red blood cell|red cells]] | ||
* Intermediate filaments and pinocytotic | * Intermediate filaments and pinocytotic vesicles in [[cytoplasm]] | ||
* Weibel-Palade bodies | * [[Weibel-Palade body|Weibel-Palade bodies]] | ||
| style="background:#F5F5F5;" align="center" | Biopsy | | style="background:#F5F5F5;" align="center" | [[Biopsy]] | ||
| style="background:#F5F5F5;" align="center" | - | | style="background:#F5F5F5;" align="center" |NA | ||
|- | |||
|Diseases | |||
|Etiology | |||
|Congenital | |||
|Acquired | |||
|Demography | |||
!Appearance | |||
!Fever | |||
!Bleeding | |||
!BP | |||
!Hepatosplenomegaly | |||
!Lymphadenopathy | |||
!Other | |||
!WBC | |||
!Hb | |||
!Plt | |||
|LFT | |||
|ESR/CRP | |||
|Histopathology | |||
|Gold standard diagnosis | |||
|Associated findings | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Masson's [[hemangioma]] <ref name="pmid22993679">{{cite journal |vauthors=Park KK, Won YS, Yang JY, Choi CS, Han KY |title=Intravascular Papillary Endothelial Hyperplasia (Masson tumor) of the Skull : Case Report and Literature Review |journal=J Korean Neurosurg Soc |volume=52 |issue=1 |pages=52–4 |date=July 2012 |pmid=22993679 |pmc=3440504 |doi=10.3340/jkns.2012.52.1.52 |url=}}</ref> | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Masson's [[hemangioma]] <ref name="pmid22993679">{{cite journal |vauthors=Park KK, Won YS, Yang JY, Choi CS, Han KY |title=Intravascular Papillary Endothelial Hyperplasia (Masson tumor) of the Skull : Case Report and Literature Review |journal=J Korean Neurosurg Soc |volume=52 |issue=1 |pages=52–4 |date=July 2012 |pmid=22993679 |pmc=3440504 |doi=10.3340/jkns.2012.52.1.52 |url=}}</ref> | ||
| style="background:#F5F5F5;" align="center" | Idiopathic | | style="background:#F5F5F5;" align="center" | | ||
| style="background:#F5F5F5;" align="center" | | * [[Idiopathic]] | ||
| style="background:#F5F5F5;" align="center" | | |||
| style="background:#F5F5F5;" align="center" | | * | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" |Rare | ||
| style="background:#F5F5F5;" align="center" | | |||
* Normal | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
Line 166: | Line 206: | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | | ||
* | * Papillary fronds lined by proliferating [[endothelium]] | ||
* Pyogenic granulomas | | style="background:#F5F5F5;" align="center" | [[Biopsy]] | ||
* | | style="background:#F5F5F5;" align="center" | | ||
* [[Hemangioma]] | |||
* [[Pyogenic granuloma|Pyogenic granulomas]] | |||
* [[Lymphangioma overview|Lymphangiomas]] | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Seborrheic keratosis]] <ref name="pmid18845088">{{cite journal |vauthors=Noiles K, Vender R |title=Are all seborrheic keratoses benign? Review of the typical lesion and its variants |journal=J Cutan Med Surg |volume=12 |issue=5 |pages=203–10 |date=2008 |pmid=18845088 |doi=10.2310/7750.2008.07096 |url=}}</ref> | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Seborrheic keratosis]] <ref name="pmid18845088">{{cite journal |vauthors=Noiles K, Vender R |title=Are all seborrheic keratoses benign? Review of the typical lesion and its variants |journal=J Cutan Med Surg |volume=12 |issue=5 |pages=203–10 |date=2008 |pmid=18845088 |doi=10.2310/7750.2008.07096 |url=}}</ref> | ||
| style="background:#F5F5F5;" align="center" | Clonal expansion of a mutated epidermal keratinocyte | | style="background:#F5F5F5;" align="center" | | ||
* Clonal expansion of a mutated epidermal [[keratinocyte]] | |||
| style="background:#F5F5F5;" align="center" | + | | style="background:#F5F5F5;" align="center" | + | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | Any age | | style="background:#F5F5F5;" align="center" | Any age | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | | ||
* Usually asymptomatic | * Usually [[asymptomatic]] | ||
* Being stuck on the skin surface | * Being stuck on the skin surface | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
Line 192: | Line 234: | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | Papillomatous epithelial proliferation containing horn cysts | | style="background:#F5F5F5;" align="center" | | ||
* Papillomatous epithelial proliferation containing horn [[Cyst|cysts]] | |||
| style="background:#F5F5F5;" align="center" | Clinical manifestations | | style="background:#F5F5F5;" align="center" | Clinical manifestations | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | | ||
* Dermatosis papulosa nigra | * [[Dermatosis papulosa nigra]] | ||
* Stucco keratosis | * Stucco keratosis | ||
* Melanoacanthoma | * Melanoacanthoma | ||
Line 201: | Line 244: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Systemic lupus erythematosus]] ([[SLE]]) <ref name="pmid22888407">{{cite journal |vauthors=Uva L, Miguel D, Pinheiro C, Freitas JP, Marques Gomes M, Filipe P |title=Cutaneous manifestations of systemic lupus erythematosus |journal=Autoimmune Dis |volume=2012 |issue= |pages=834291 |date=2012 |pmid=22888407 |pmc=3410306 |doi=10.1155/2012/834291 |url=}}</ref> | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Systemic lupus erythematosus]] ([[SLE]]) <ref name="pmid22888407">{{cite journal |vauthors=Uva L, Miguel D, Pinheiro C, Freitas JP, Marques Gomes M, Filipe P |title=Cutaneous manifestations of systemic lupus erythematosus |journal=Autoimmune Dis |volume=2012 |issue= |pages=834291 |date=2012 |pmid=22888407 |pmc=3410306 |doi=10.1155/2012/834291 |url=}}</ref> | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | | ||
* Erythema on the nasolabial folds | * [[Idiopathic]] | ||
* Macular or diffusely erythematous in sun-exposed areas | |||
* | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | More common in female, typically in the 20 to 30 years | |||
| style="background:#F5F5F5;" align="center" | | |||
* [[Erythema]] on the [[Mouth|nasolabial folds]] | |||
* [[Macule|Macular]] or diffusely erythematous in sun-exposed areas | |||
* Discoid rash | * Discoid rash | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | ± | ||
| style="background:#F5F5F5;" align="center" | - | | style="background:#F5F5F5;" align="center" | - | ||
| style="background:#F5F5F5;" align="center" | ↑ | | style="background:#F5F5F5;" align="center" | ↑ | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | ± | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | ± | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | | ||
* Weight loss | * [[Weight loss]] | ||
* Headache | * [[Headache]] | ||
* Arthralgia | * [[Arthralgia]] | ||
* Myalgia | * [[Myalgia]] | ||
* Nausea and | * [[Nausea and vomiting|Nausea]] | ||
* Pleuritic chest pain | * [[Dyspepsia]] | ||
* Dyspnea | * [[Pleuritic chest pain]] | ||
* Hematuria | * [[Dyspnea]] | ||
* [[Hematuria]] | |||
| style="background:#F5F5F5;" align="center" | ↑ | | style="background:#F5F5F5;" align="center" | ↑ | ||
| style="background:#F5F5F5;" align="center" | ↓ | | style="background:#F5F5F5;" align="center" | ↓ | ||
Line 256: | Line 303: | ||
| style="background:#F5F5F5;" align="center" | Any age, usually in 20-30 years | | style="background:#F5F5F5;" align="center" | Any age, usually in 20-30 years | ||
| style="background:#F5F5F5;" align="center" | Painless red lesion (lobular capillary hemangioma) | | style="background:#F5F5F5;" align="center" | Painless red lesion (lobular capillary hemangioma) | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | + | | style="background:#F5F5F5;" align="center" | + | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
Line 272: | Line 319: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Benign lymphangioendothelioma <ref name="pmid10935645">{{cite journal |vauthors=Guillou L, Fletcher CD |title=Benign lymphangioendothelioma (acquired progressive lymphangioma): a lesion not to be confused with well-differentiated angiosarcoma and patch stage Kaposi's sarcoma: clinicopathologic analysis of a series |journal=Am. J. Surg. Pathol. |volume=24 |issue=8 |pages=1047–57 |date=August 2000 |pmid=10935645 |doi= |url=}}</ref> | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Benign lymphangioendothelioma <ref name="pmid10935645">{{cite journal |vauthors=Guillou L, Fletcher CD |title=Benign lymphangioendothelioma (acquired progressive lymphangioma): a lesion not to be confused with well-differentiated angiosarcoma and patch stage Kaposi's sarcoma: clinicopathologic analysis of a series |journal=Am. J. Surg. Pathol. |volume=24 |issue=8 |pages=1047–57 |date=August 2000 |pmid=10935645 |doi= |url=}}</ref> | ||
| style="background:#F5F5F5;" align="center" | Idiopathic | | style="background:#F5F5F5;" align="center" | | ||
| style="background:#F5F5F5;" align="center" | | * [[Idiopathic]] | ||
* | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | + | | style="background:#F5F5F5;" align="center" | + | ||
| style="background:#F5F5F5;" align="center" | Any ages, median age is 50 years | | style="background:#F5F5F5;" align="center" | Any ages, median age is 50 years | ||
| style="background:#F5F5F5;" align="center" | single, slowly expanding patch, plaque, or nodule | | style="background:#F5F5F5;" align="center" | single, slowly expanding patch, plaque, or nodule | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
Line 293: | Line 343: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Cavernous [[hemangioma]] <ref name="pmid229814">{{cite journal |vauthors=Goldberg RE, Pheasant TR, Shields JA |title=Cavernous hemangioma of the retina. A four-generation pedigree with neurocutaneous manifestations and an example of bilateral retinal involvement |journal=Arch. Ophthalmol. |volume=97 |issue=12 |pages=2321–4 |date=December 1979 |pmid=229814 |doi= |url=}}</ref> | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Cavernous [[hemangioma]] <ref name="pmid229814">{{cite journal |vauthors=Goldberg RE, Pheasant TR, Shields JA |title=Cavernous hemangioma of the retina. A four-generation pedigree with neurocutaneous manifestations and an example of bilateral retinal involvement |journal=Arch. Ophthalmol. |volume=97 |issue=12 |pages=2321–4 |date=December 1979 |pmid=229814 |doi= |url=}}</ref> | ||
| style="background:#F5F5F5;" align="center" | Idiopathic | | style="background:#F5F5F5;" align="center" | | ||
| style="background:#F5F5F5;" align="center" | | * [[Idiopathic]] | ||
| style="background:#F5F5F5;" align="center" | | |||
* | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | Usually in third to fifth decades of life. | | style="background:#F5F5F5;" align="center" | Usually in third to fifth decades of life. | ||
| style="background:#F5F5F5;" align="center" | Painless, slowly progressive protrusion or bulging of their globe | | style="background:#F5F5F5;" align="center" | Painless, slowly progressive protrusion or bulging of their globe | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | | | style="background:#F5F5F5;" align="center" | – | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
| style="background:#F5F5F5;" align="center" | Nl | | style="background:#F5F5F5;" align="center" | Nl | ||
Line 317: | Line 370: | ||
* Visual field deficits | * Visual field deficits | ||
|- | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|} | |} | ||
Revision as of 17:35, 4 October 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2] Haytham Allaham, M.D. [3]
Kaposi's sarcoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Kaposi's sarcoma differential diagnosis On the Web |
American Roentgen Ray Society Images of Kaposi's sarcoma differential diagnosis |
Risk calculators and risk factors for Kaposi's sarcoma differential diagnosis |
Overview
Kaposi's sarcoma must be differentiated from other diseases that cause similar cutaneous, pulmonary, and gastrointestinal involvement, such as bacillary angiomatosis, AIDS-related lymphoma, and seborrheic keratosis.
Differentiating Kaposi's Sarcoma from other Diseases
- Kaposi's sarcoma must be differentiated from other diseases that cause similar cutaneous, pulmonary, and gastrointestinal involvement.[1][2][3]
Diseases | Etiology | Congenital | Acquired | Demography | Clinical manifestations | Lab findings | Gold standard diagnosis | Associated findings | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Signs | CBC | LFT | ESR/CRP | Histopathology | ||||||||||||||
Appearance | Fever | Bleeding | BP | Hepatosplenomegaly | Lymphadenopathy | Other | WBC | Hb | Plt | ||||||||||
Bacillary angiomatosis [4] | – | + | Any age, usually between 20 -50 years | Solitary or multiple red, purple, flesh-colored, or colorless papules | ± | ± | Nl | – | – | Nl | Nl | Nl | Nl | Nl |
|
Clinical manifestation | |||
Arteriovenous malformation [5] |
|
+ | – | Any age | Nl | – | + | Nl | – | – | Nl | Nl | Nl | Nl | Nl | NA | Imaging | ||
Acroangiodermatitis[6] |
|
– | – | Any age, more in males | Purplish-blue to brown papules and plaques | – | – | Nl | – | – |
|
Nl | Nl | Nl | Nl | Nl |
|
Clinical manifesttations | |
Angiosarcoma [7] |
|
– | – | Adults, more in males | Enlarging bruise, a blue-black nodule, or an unhealed ulceration | – | – | Nl | – | – | – | Nl | ↓ | ↓ | Nl | Nl |
|
Biopsy | NA |
Diseases | Etiology | Congenital | Acquired | Demography | Appearance | Fever | Bleeding | BP | Hepatosplenomegaly | Lymphadenopathy | Other | WBC | Hb | Plt | LFT | ESR/CRP | Histopathology | Gold standard diagnosis | Associated findings |
Masson's hemangioma [8] |
|
– | – | Rare |
|
– | – | Nl | – | – | – | Nl | Nl | Nl | Nl | Nl |
|
Biopsy | |
Seborrheic keratosis [9] |
|
+ | – | Any age |
|
– | – | Nl | – | – | – | Nl | Nl | Nl | Nl | Nl |
|
Clinical manifestations |
|
Systemic lupus erythematosus (SLE) [10] |
|
– | – | More common in female, typically in the 20 to 30 years |
|
± | - | ↑ | ± | ± | ↑ | ↓ | ↓ | - | Nl |
|
Clinical manifestations |
| |
Pyogenic granuloma [11] |
|
+ | + | Any age, usually in 20-30 years | Painless red lesion (lobular capillary hemangioma) | – | + | Nl | – | – | – | Nl | Nl | Nl | Nl | Nl | Neutrophilic infiltration, hemorrhage, necrosis of the overlying epidermis | Clinical manifestation | - |
Benign lymphangioendothelioma [12] |
|
– | + | Any ages, median age is 50 years | single, slowly expanding patch, plaque, or nodule | – | – | Nl | – | – | – | Nl | Nl | Nl | Nl | Nl | Thin-walled endothelial-lined spaces that are interspersed between strands of collagen | Clinical manifestation and biopsy | - |
Cavernous hemangioma [13] |
|
– | – | Usually in third to fifth decades of life. | Painless, slowly progressive protrusion or bulging of their globe | – | – | Nl | – | – | – | Nl | Nl | Nl | Nl | Nl | Engorged vascular channels, which are tightly knit and separated by fibrous septae | Clinical manidestation |
|
References
- ↑ Kaposi's Sarcoma. Radiopaedia (2015) http://radiopaedia.org/articles/kaposi-sarcoma Accessed on January, 19 2016
- ↑ Libre Pathology. Kaposi's sarcoma (2015) http://librepathology.org/wiki/index.php/File:Kaposi_sarcoma_low_intermed_mag.jpg Accessed on January, 19 2016
- ↑ Kaposi's Sarcoma. PathologyOutlines (2015) http://www.pathologyoutlines.com/topic/skintumornonmelanocytickaposisarcoma.html Accessed on January, 19 2015
- ↑ Tappero JW, Perkins BA, Wenger JD, Berger TG (July 1995). "Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus". Clin. Microbiol. Rev. 8 (3): 440–50. PMC 174635. PMID 7553576.
- ↑ Whitehead KJ, Smith MC, Li DY (February 2013). "Arteriovenous malformations and other vascular malformation syndromes". Cold Spring Harb Perspect Med. 3 (2): a006635. doi:10.1101/cshperspect.a006635. PMC 3552339. PMID 23125071.
- ↑ Lugović L, Pusić J, Situm M, Buljan M, Bulat V, Sebetić K, Soldo-Belić A (2007). "Acroangiodermatitis (pseudo-Kaposi sarcoma): three case reports". Acta Dermatovenerol Croat. 15 (3): 152–7. PMID 17868541.
- ↑ Barttelbort SW, Stahl R, Ariyan S (July 1989). "Cutaneous angiosarcoma of the face and scalp". Plast. Reconstr. Surg. 84 (1): 55–9. PMID 2734404.
- ↑ Park KK, Won YS, Yang JY, Choi CS, Han KY (July 2012). "Intravascular Papillary Endothelial Hyperplasia (Masson tumor) of the Skull : Case Report and Literature Review". J Korean Neurosurg Soc. 52 (1): 52–4. doi:10.3340/jkns.2012.52.1.52. PMC 3440504. PMID 22993679.
- ↑ Noiles K, Vender R (2008). "Are all seborrheic keratoses benign? Review of the typical lesion and its variants". J Cutan Med Surg. 12 (5): 203–10. doi:10.2310/7750.2008.07096. PMID 18845088.
- ↑ Uva L, Miguel D, Pinheiro C, Freitas JP, Marques Gomes M, Filipe P (2012). "Cutaneous manifestations of systemic lupus erythematosus". Autoimmune Dis. 2012: 834291. doi:10.1155/2012/834291. PMC 3410306. PMID 22888407.
- ↑ Kamal R, Dahiya P, Puri A (January 2012). "Oral pyogenic granuloma: Various concepts of etiopathogenesis". J Oral Maxillofac Pathol. 16 (1): 79–82. doi:10.4103/0973-029X.92978. PMC 3303528. PMID 22434943.
- ↑ Guillou L, Fletcher CD (August 2000). "Benign lymphangioendothelioma (acquired progressive lymphangioma): a lesion not to be confused with well-differentiated angiosarcoma and patch stage Kaposi's sarcoma: clinicopathologic analysis of a series". Am. J. Surg. Pathol. 24 (8): 1047–57. PMID 10935645.
- ↑ Goldberg RE, Pheasant TR, Shields JA (December 1979). "Cavernous hemangioma of the retina. A four-generation pedigree with neurocutaneous manifestations and an example of bilateral retinal involvement". Arch. Ophthalmol. 97 (12): 2321–4. PMID 229814.